Skip to main content
English homeNews home
Story
10 of 50

Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk - The Wall Street Journal

Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk  The Wall Street Journal Pfizer sues to stop rival bid for drugmaker Metsera by Denmark's Novo Nordisk  ABC News Pfizer sues Novo Nordisk, Metsera for breach of merger agreement  statnews.com Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid  Reuters Pfizer Receives Early Clearance from U.S. Federal Trade Commission for Metsera Acquisition  Yahoo Finance

Latest News